| Filed On | Filing |
|---|---|
| 04 Sep 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 28 Aug 2026 | WITHDRAWAL REQUEST |
| 28 Aug 2026 | REGISTRATION STATEMENT |
| 21 Aug 2026 | 8-K: Financial Statements and Exhibits |
| 21 Aug 2026 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated balance sheets of DiamiR Biosciences Corp. (the “Company”) as of May 31, 2026 and 2025, the related consolidated statements of operations, stockholders’ deficit and cash flows for each of the... |
| 13 Aug 2026 | 3 |
| 13 Aug 2026 | 3 |
| 07 Aug 2026 | 8-K: Other Events |
| 28 Jul 2026 | 3 |
| 24 Jul 2026 | SCHEDULE 13D |
| 24 Jul 2026 | 3 |
| 24 Jul 2026 | 3 |
| 20 Jul 2026 | 8-K: Completion of Acquisition or Disposition of Assets; Material Modification to Rights of Security Holders +3 more |
| 22 Jun 2026 | AMENDMENT NO. 1 TO FORM 6-K |
| 10 Jun 2026 | REPORT OF FOREIGN PRIVATE ISSUER |
| 04 Jun 2026 | PROSPECTUS |
| 03 Jun 2026 | EFFECT |
| 29 May 2026 | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 |
| 14 May 2026 | CURRENT REPORT |
| 13 May 2026 | EFFECT |
Loading...
